Plug-ins are used for specialist cardiac assessment including VentricularTools for left ventricular assessment and ThalassaemiaTools for T2* image quantification. It is important that CMRtools is only used to view and analyze human cardiac and or liver images acquired with a cardiovascular magnetic resonance scanner. CMRtools must not be used to view or analyze images acquired with any other type of imaging device.

The software must not be used to view or analyze images of any part of the body except the heart and or liver or the vascular system. Furthermore, the software must not be used to view or analyze images acquired from animals.

Only DICOM images will be used for presentation, display and diagnosis.

Device Description

CMRtools™ is a software package for the visualization and analysis of cardiovascular magnetic resonance images (CMR). CMRtools™ is comprised of an image loader, an image viewer and a set of optional plug-ins for specialist cardiac analysis, including VentricularTools and ThalassaemiaTools.

VentricularTools provides dedicated functionality for calculating volume and mass indices of the . ventricles of the heart from magnetic resonance images.
ThalassaemiaTools allows the calculation of a property called T2* that characterizes iron loading . in the heart and liver.

CMRtools™ allows high performance image manipulation, 3D visualization, and advanced image processing on a standard PC without dedicated hardware. All software plug-ins have comprehensive quantification facilities with full analysis session record for providing comprehensive audit trails.

AI/ML Overview

The provided text does not contain specific acceptance criteria, study details, or performance metrics for the CMRtools and plug-ins VentricularTools & ThalassaemiaTools. The document is a 510(k) summary for pre-market notification, which focuses on demonstrating substantial equivalence to predicate devices rather than providing detailed performance studies.

Therefore, I cannot populate the table or answer the questions regarding acceptance criteria, study design, sample sizes, expert qualifications, or ground truth establishment based on the provided text.

The text does indicate that:

Testing was done: "CMRtools and plug-ins have been tested according to the specifications that are documented in a Software Test Plan. Testing is an integral part Cardiovascular Imaging Solutions Ltd. software development process as described in the company's Product Development Process." This confirms a testing process exists but doesn't provide details.
Hazard analysis was performed: "The submission contains the results of a hazard analysis and the "Level of Concern for potential hazards has been classified as "Minor"."

Without the actual "Software Test Plan" or specific study reports, the detailed information requested cannot be extracted.

Summary

{0}------------------------------------------------

Ko 73194
10/2

510(k) Summary of Safety and Effectiveness

Date Prepared

November 10, 2007

Submitter's Information

Professor Guang-Zhong Yang, Director Cardiovascular Imaging Solutions Ltd. 53 Cavendish Road, London SW12 OBL, UK Tel: 011 44(0)7771 888 886

Contact Person

Mr. Robert Merrifield Cardiovascular Imaging Solutions Ltd. 53 Cavendish Road, London SW12 OBL, UK Tel: 011 44(0)7771 888 886

Device Name

Common/Usual Name:	Picture Archiving Communications System
Proprietary Name:	CMRtools and plug-ins VentricularTools & ThalassaemiaTools
Classification Names:	System, image processing, radiological 892.2050 90-LLZ

Substantially Equivalent to both:

510(k) Number	K060941	K994283
Device Classification Name	system, image processing,radiological	system, nuclear magnetic resonanceimaging
Device Name	CAAS MRV VERSION 3.0	MRI- MAGNETIC RESONANCEANALYTICAL SOFTWARE SYSTEM
Applicant	PIE MEDICAL IMAGING B.V.7450 Flying Cloud Dr.Eden Prairie, MN 55344	MEDIS MEDICAL IMAGINGSYSTEMS, B.V.Poortgebouw Rijnsburgerweg 10Leiden, NL 2333 AA
Regulation Number	892.2050	892.1000
Classification Product Code	LLZ	LNH
Decision Date	04/19/2006	08/30/2000
Decision	substantially equivalent (SE)	substantially equivalent (SE)
Classification AdvisoryCommittee	Radiology	Radiology

Device Description

VentricularTools provides dedicated functionality for calculating volume and mass indices of the . ventricles of the heart from magnetic resonance images.
ThalassaemiaTools allows the calculation of a property called T2* that characterizes iron loading . in the heart and liver.

{1}------------------------------------------------

Kó 73/94
20f2

510(k) Summary of Safety and Effectiveness

Indications for Use

CMRtools™ and plug-ins VentricularTools™ & ThalassaemiaTools™ is a software device used for viewing and analyzing cardiovascular magnetic resonance images. It allows high performance image manipulation, 3D visualization, and advanced image processing on a standard PC without dedicated hardware. All software plug-ins have comprehensive quantification facilities with full analysis session recording for providing comprehensive audit trails. It contains an image viewer for importing DICOM images, browsing through patient datasets, viewing cine images and performing region-of-interest analysis. Plug-ins are used for specialist cardiac assessment including VentricularTools for left ventricular assessment and ThalassaemiaTools for T2* image quantification. It is important that CMRtools is only used to view and analyze human cardiac and or liver images acquired with a cardiovascular magnetic resonance scanner. CMRtools must not be used to view or analyze images acquired with any other type of imaging device. The software must not be used to view or analyze images of any part of the body except the heart and or liver or the vascular system. Furthermore, the software must not be used to view or analyze images acquired from animals. Only DICOM images will be used for presentation, display and diagnosis.

Technological Characteristics

CMRtools and plug-ins is a stand-alone software package which can be used on more than one hardware platform, as long as minimum hardware requirements are met. The device does not contact the patient, nor does it control any life-sustaining devices. A physician providing ample opportunity for competent human intervention interprets images and information being displayed and/or printed.

CMRtools and its plug-ins require a PC or a laptop with a mouse, keyboard and display running Microsoft Windows XP/Vista with a 1GHz processor, 512MB RAM, 128MB graphics card and 2GB of free hard disk space. The user interacts with CMRtools and its plug-ins using a desktop or laptop computer with a keyboard, mouse and display. The Software utilizes the standard point-and-click approach to user interface design that is ubiquitous on modern windowing operating systems.

CMRtools provides a user interface with individual items for selecting images, changing the brightness/contrast and accessing the different aspects of functionality. The plug-ins for CMRtools make use of a workflow orientated graphical user interface that guides the User through the analysis process by presenting a set of simple tasks. Each aspect of the software is clearly documented with context-sensitive Interactive Help. CMRtools and its plug-ins are designed to be used after the scanning of the patient is complete. The images will typically be transferred via a CD, network drive or though a PACS transfer from the scanner onto the clinician's local machine. Image viewing and analysis can then be performed without connection to the internet or a network.

Testing

CMRtools and plug-ins have been tested according to the specifications that are documented in a Software Test Plan. Testing is an integral part Cardiovascular Imaging Solutions Ltd. software development process as described in the company's Product Development Process.

Conclusion

The 510(k) pre-market notification for the CMRtools and plug-ins VentricularTools & ThalassaemiaTools contains adequate information and data to enable FDA-CDRH to determine substantial equivalence to the predicate device.

The device has been and will continue to be manufactured according to the voluntary standards 1. list in the Voluntary Standards section of the submission.
The submission contains the results of a hazard analysis and the "Level of Concern for potential 2. hazards has been classified as "Minor".

{2}------------------------------------------------

DEPARTMENT OF HEALTH & HUMAN SERVICES

Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle with three stripes extending from its back, representing the department's commitment to health, human services, and well-being. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the eagle.

Public Health Service

2000 ।

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

Cardiovascular Imaging Solutions Ltd. c/o Mr. Carl Thomas, Consultant OTech, Inc. 1600 Manchester Way CORINTH TX 76210

K073194 Re:

Trade/Device Name: CMRtools" and plug-ins VentricularTools & Thalassaemia Tools Regulation Number: 21 CFR §892.2050 Regulation Name: Picture archiving and communications system

Regulatory Class: II Product Code: LLZ

Dated: November 12, 2007 Received: November 13, 2007

Dear Mr. Thomas:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{3}------------------------------------------------

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at one of the following numbers, based on the regulation number at the top of this letter.

21 CFR 876.xxxx	(Gastroenterology/Renal/Urology)	240-276-0115
21 CFR 884.xxxx	(Obstetrics/Gynecology)	240-276-0115
21 CFR 892.xxxx	(Radiology)	240-276-0120
Other		240-276-0100

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at 240-276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at 240-276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers. International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely vours.

Nancy C. Brogdon

Nancy C. Brogdon Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{4}------------------------------------------------

TAB2

510(k) Number:

Device Name:

CMRtools™ and plug-ins VentricularTools™ & ThalassaemiaTools™

Indications for Use:

Only DICOM images will be used for presentation, display and diagnosis.

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use AND/OR (Part 21 CFR 801 Subpart D)

Over-The-Counter Use (21 CFR 807 Subpart C)

hogu Whha

Division of Reproductive, Abdominal and
Radiological Devices
510(k) Number Ko73194

Regulation Number and Section

§ 892.2050 Medical image management and processing system.

(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).